Key facts
- This page summarizes David M. Johnson's Form 4 filing for Aura Biosciences, Inc. (AURA).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Oct 2023, 19:56.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Purchase
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $8.00 to $8.51, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $8.52 to $8.66, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
Footnote F3
Velosity Capital Management LLC is an entity that the reporting person is the sole member of.
Footnote F4
The shares are held by the NEJ09 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.
Footnote F5
The shares are held by the NEJ12 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.